Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORE
Antibody-based therapeutics are of great value for the treatment of human diseases. In addition to functional activity, affinity, or physico-chemical properties, antibody specificity is considered to be one of the most crucial attributes for safety and efficacy. Creative Biolabs provides antibody specificity profile assay to determine the antibody reactivity against human leukocyte antigen (HLA).
Antibody microarray, also known as antibody array, is a specific form of protein microarray. In this technology, a collection of captured antibodies is spotted and fixed on a solid surface including glass, plastic, membrane, or silicon chip, and the interaction between the antibody and its target antigen is detected. Antibody microarray is often used for detecting protein expression from various biofluids including serum, plasma, and cell or tissue lysates.
Fig.1 Schematic of antibody microarray.Distributed under CC BY-SA 4.0, from Wiki, without modification.
Antibody specificity profiling is used to examine antibody reactivity against lots of human protein targets under either native or denaturing conditions. Since these putative targets are relatively homogeneous with regard to concentration and represent the vast majority of the human proteome, antibody specificity profiling represents the most unbiased and informative means to evaluate antibody sensitivity and specificity. Antibody specificity profiling is often used for verifying reagents critical to basic science or prioritizing therapeutic large molecules.
Tips: When multiple antibodies are profiled simultaneously, only one positive and negative control will be performed.
Timeline: 4 to 6 weeks
Delivery:
As a leader in HLA antibody detection service, Creative Biolabs offers a full range portfolio of assays for low- to high-resolution detection. We also offer the most cost-effective multiplex assays and a wide range of singleplex kits. For more information, please feel free to contact us directly.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
